A meta-analysis of randomized controlled trials (RCTs) including patients with HF found no improvement in hospitalization rates or echocardiographic parameters such as LVEF or LV end-systolic or diastolic volume
section 1833(t)(6) of the Act provides for temporary additional payments, which we refer to as transitional pass-through payments, for at least 2 but not more than 3 years for certain drugs, biological agents, brachytherapy devices used for the treatment of cancer, and categories of other medical devices
Targeting the mutant p53 secretome
Burghen GA, Christensen ML, Kritchevsky SB, West B, Rose SR, Faulkner MS, Parnell DI, Broome DC, Danish R, Velasquez-Mieyer P, Lustig R: Characteristics of Type 1 and Type 2 new-onset diabetes in children